Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study

被引：0
|
作者：
Jorge Millán-Pascual
Gabriel Valero-López
Francisca Iniesta-Martinez
Maria Fuensanta Hellin-Gil
Judith Jimenez-Veiga
Isabel Alejandra López-Tovar
Ana Morales-Ortiz
José. E. Meca-Lallana
机构：
[1] Virgen de la Arrixaca University Hospital (IMIB-Arrixaca),Multiple Sclerosis CSUR and Clinical Neuroimmunology Unit, Neurology Department
[2] UCAM,Clinical Neuroimmunology and Multiple Sclerosis Cathedra
[3] Universidad Católica San Antonio,Preventive Medicine Service
[4] Virgen de la Arrixaca University Hospital (IMIB-Arrixaca),undefined
来源：
Neurology and Therapy | 2024年 / 13卷
关键词：
COVID-19; Multiple sclerosis; SARS-CoV-2 vaccination; Serological response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：153 / 164
页数：11
相关论文
共 50 条
  • [1] Humoral Response to SARS-COV-2 Vaccination in Patients with Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder: A Real-World Study
    Millan-Pascual, Jorge
    Valero-Lopez, Gabriel
    Iniesta-Martinez, Francisca
    Hellin-Gil, Maria Fuensanta
    Jimenez-Veiga, Judith
    Lopez-Tovar, Isabel Alejandra
    Morales-Ortiz, Ana
    Meca-Lallana, Jose. E.
    NEUROLOGY AND THERAPY, 2024, 13 (01) : 153 - 164
  • [2] Relapses after SARS-CoV-2 vaccination in patients with neuromyelitis optica spectrum disorder and multiple sclerosis
    Kong, Lingyao
    Wang, Xiaofei
    Chen, Hongxi
    Shi, Ziyan
    Lang, Yanlin
    Zhang, Ying
    Zhou, Hongyu
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 68
  • [3] Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
    Ibrahim, M.
    Maillart, E.
    Abdi, B.
    Papeix, C.
    Stankoff, B.
    Dubessy, A. -L.
    Bensa, C.
    Creange, A.
    Chamekh, Z.
    Lubetzki, C.
    Marcelin, A. -G.
    Corvol, J. -C.
    Pourcher, V.
    Louapre, C.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 637 - 638
  • [4] Anti-CD20 therapies decrease humoral immune response to SARS-CoV-2 in patients with multiple sclerosis or neuromyelitis optica spectrum disorders
    Louapre, Celine
    Ibrahim, Michella
    Maillart, Elisabeth
    Abdi, Basma
    Papeix, Caroline
    Stankoff, Bruno
    Dubessy, Anne-Laure
    Bensa-Koscher, Caroline
    Creange, Alain
    Chamekh, Zina
    Lubetzki, Catherine
    Marcelin, Anne-Genevieve
    Corvol, Jean-Christophe
    Pourcher, Valerie
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (01): : 24 - 31
  • [5] Onset of Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Post-SARS-CoV-2 Vaccination: A Case Series Report
    Hanganu, Andreea
    Ghiuta, Alexandra
    Docan, Maria
    Zurini, Lorenzo
    Toron, Basel
    Arbune, Anca
    Anghel, Daniela Cristina
    Dulamea, Adriana Octaviana
    MULTIPLE SCLEROSIS JOURNAL, 2024, 30 (03) : 889 - 890
  • [6] SARS-COV-2 infection impact on patients with multiple sclerosis and neuromyelitis spectrum disorder in a Colombia cohort
    Cardona, P.
    Jimenez, J.
    Franco, C. A.
    Tobon, J. V.
    Munoz, N. L.
    Restrepo-Aristizabal, C.
    Rodriguez-Marquez, I.
    Zuluaga, M.
    MULTIPLE SCLEROSIS JOURNAL, 2021, 27 (2_SUPPL) : 322 - 322
  • [7] Surrogates for SARS-CoV-2 vaccination response in multiple sclerosis identified in a real world scenario
    Schraad, M.
    Uphaus, T.
    Runkel, S.
    Hitzler, W.
    Bittner, S.
    Zipp, F.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 988 - 988
  • [8] COVID-19 and vaccination against SARS-CoV-2 in patients with neuromyelitis optica spectrum disorders
    Jovicevic, Vanja
    Ivanovic, Jovana
    Andabaka, Marko
    Tamas, Olivera
    Veselinovic, Nikola
    Momcilovic, Nikola
    Mesaros, Sarlota
    Pekmezovic, Tatjana
    Drulovic, Jelena
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 57
  • [9] Humoral immune response to SARS-CoV-2 booster vaccination in patients with multiple sclerosis and healthy controls
    Krajnc, N.
    Riedl, K.
    Hegen, H.
    Traxler, G.
    Leutmezer, F.
    Di Pauli, F.
    Kornek, B.
    Rommer, P.
    Zulehner, G.
    Duerauer, S.
    Bauer, A.
    Kratzwald, S.
    Winklehner, M.
    Deisenhammer, F.
    Guger, M.
    Hoeftberger, R.
    Berger, T.
    Bsteh, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2022, 29 : 793 - 793
  • [10] The efficacy of rituximab in patients with neuromyelitis optica spectrum disorder: A real-world study from Turkey
    Uzunkopru, Cihat
    Tutuncu, Melih
    Gunduz, Tuncay
    Gumus, Haluk
    Sen, Sedat
    Demir, Serkan
    Cinar, Bilge Piri
    Ture, Hatice Sabiha
    Uygunoglu, Ugur
    Togrol, Rifat Erdem
    Terzi, Murat
    Kurtuncu, Murat
    Ozakbas, Serkan
    Tutuncu, Mesude
    Beckmann, Yesim
    Siva, Aksel
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (07)
12345